OpenVSafe by OpenVAERS
Search V-safe

8E8-28475-21830

2 vaccinations 6 coded responses 18 check-ins 6 free-text entries 2 call cases
Sex
Female
Age at first dose
66+
ZIP prefix
577 / SD
Registered
2021-02-25
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-25
    Registered in v-safe
  2. 2021-02-25
    Dose 1 — Pfizer-BioNTech
  3. 2021-02-25
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-02-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-02-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-02-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-03-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-03-04
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-03-13
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-03-18
    Dose 2 — Pfizer-BioNTech
  11. 2021-03-20
    Survey response — days 1–6 daily, dose 2
    MedDRA: Erythema, Self-medication, Urticaria — Feeling: Fair · Site: Swelling · Rash, not including the immediate area around the injection site
    Free text: Hive like swelling occurred approx 8 hrs after shot. Very severe (hive on cheek). Took Claritin that evening and day after. Today hive is down and redness minimized.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-03-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Rash, not including the immediate area around the injection site
    Adult check-in
  13. 2021-03-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Rash, not including the immediate area around the injection site
    Adult check-in
  14. 2021-03-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Rash, not including the immediate area around the injection site
    Adult check-in
  15. 2021-04-02
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-04-08
    Survey response — day 21, dose 2
    MedDRA: Hypersensitivity, Pre-existing disease, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional
    Free text: Symptoms: Allergies have worsened · Healthcare visit (other): Allergist appointment set. for next week
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-04-08
    Report sent to call center — day 21, dose 2
    Get care from a doctor or other healthcare professional
    no matching call case
  18. 2021-04-15
    Survey response — day 28, dose 2
    MedDRA: Erythema, Office visit, Urticaria — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: Hive and redness on face · Healthcare visit (other): Also saw allergist md
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-04-15
    Report sent to call center — day 28, dose 2
    Get care from a doctor or other healthcare professional
    no matching call case
  20. 2021-04-23
    Survey response — day 35, dose 2
    MedDRA: Rash — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Face rash on cheeks spread to nose.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-04-23
    Report sent to call center — day 35, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  22. 2021-05-01
    Survey response — day 42, dose 2
    MedDRA: Rash — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: I stiil have face rash flareups. Cheeks get red and nose also gets red and appears swollen.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-05-01
    Report sent to call center — day 42, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  24. 2021-06-19
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-09-16
    Survey response — 6 months, dose 2
    MedDRA: Rash — Feeling: Good
    Free text: Skin rash still appears off and on. Never had this before second shot.
    MedDRA releases: 2024-11 · check-in free text available
  26. 2022-03-02
    Call successful
    Does not wish to fill out VAERS report

Vaccinations

DoseDateManufacturerCo-administered
12021-02-25Pfizer-BioNTech
22021-03-18Pfizer-BioNTech

Call center

2 call center cases

2 successful

2 check-ins flagged for a call with no call center case on record

See the call center timeline

Free text

Release 6 — days 1–6 daily, dose 2

2021-03-20

Systemic reaction (other): Hive like swelling occurred approx 8 hrs after shot. Very severe (hive on cheek). Took Claritin that evening and day after. Today hive is down and redness minimized.

Release 7 — day 21, dose 2

2021-04-08

Symptoms: Allergies have worsened
Healthcare visit (other): Allergist appointment set. for next week

Release 7 — day 28, dose 2

2021-04-15

Symptoms: Hive and redness on face
Healthcare visit (other): Also saw allergist md

Release 7 — day 35, dose 2

2021-04-23

Symptoms: Face rash on cheeks spread to nose.

Release 8 — day 42, dose 2

2021-05-01

Symptoms: I stiil have face rash flareups. Cheeks get red and nose also gets red and appears swollen.

Release 9 — 6 months, dose 2

2021-09-16

Symptoms: Skin rash still appears off and on. Never had this before second shot.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit ✓ ✓ ✓
HCVOUnevaluable event ✓ ✓ ✓
SDErythema ✓ ✓ ✓
SDHypersensitivity ✓ ✓ ✓
SDPre-existing disease ✓ ✓ ✓
SDRash ✓ ✓ ✓
SDUrticaria ✓ ✓ ✓
SROErythema ✓ ✓ ✓
SROSelf-medication ✓ ✓ ✓
SROUrticaria ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release